Jiebai Zhou
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical phenotyping of polymyxin-associated nephrotoxicity and phenotype-specific prognostic utility of neutrophil-to-platelet ratio in carbapenem-resistant Acinetobacter baumannii infections.
Journal: BMC infectious diseases
Published: November 18, 2025
A Degradable Nanoplatform Integrating Glucose Oxidase and Copper Selenide for Near-Infrared-Enhanced Multimodal Synergistic Therapy in Lung Cancer.
Journal: Biomaterials research
Published: October 16, 2025
Risk stratification for Pseudomonas LRTI in immunocompromised patients: A LASSO-logistic regression model with clinical implications.
Journal: Medicine
Published: April 14, 2025
MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cancer.
Journal: Molecular oncology
Published: October 08, 2024
Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features.
Journal: Frontiers in oncology
Published: June 09, 2023
Resistance to immune checkpoint inhibitors in advanced lung cancer: Clinical characteristics, potential prognostic factors and next strategy.
Journal: Frontiers in immunology
Published: November 03, 2022
Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma.
Journal: BMC pulmonary medicine
Published: July 07, 2022
Pyrroloquinoline Quinone Administration Alleviates Allergic Airway Inflammation in Mice by Regulating the JAK-STAT Signaling Pathway.
Journal: Mediators of inflammation
Published: January 25, 2022
Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 19, 2021
Impact of chronic obstructive pulmonary disease on immune checkpoint inhibitor efficacy in advanced lung cancer and the potential prognostic factors.
Journal: Translational lung cancer research
Published: June 24, 2021
Clinical outcomes of patients with HER2-mutant advanced lung cancer: chemotherapies versus HER2-directed therapies.
Journal: Therapeutic advances in medical oncology
Published: January 11, 2020
Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer.
Journal: Journal of translational medicine
Published: September 08, 2014
Last Updated: 09/26/2026